The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication

被引:92
作者
Kim, Mi Na [2 ,3 ]
Kim, Nayoung [1 ,2 ,3 ]
Lee, Sang Hyup [1 ]
Park, Young Soo [1 ,2 ,3 ]
Hwang, Jin-Hyeok [1 ,2 ,3 ]
Kim, Jin-Wook [1 ]
Jeong, Sook-Hyang [1 ]
Lee, Dong Ho [1 ,2 ,3 ]
Kim, Joo Sung [2 ,3 ]
Jung, Hyun Chae [2 ,3 ]
Song, In Sung [2 ,3 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Gyeonggi Do, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
[3] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
关键词
Helicobacter pylori; probiotics; PPI-triple therapy;
D O I
10.1111/j.1523-5378.2008.00601.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: This study was performed to evaluate whether the addition of probiotics to proton pump inhibitor (PPI)-based triple therapy increases the likelihood of successful Helicobacter pylori eradication. Materials and Methods: Three hundred and forty-seven H. pylori-infected patients were randomized into a triple-plus-yogurt group (yogurt group, n = 168) or a triple-only group (control group, n = 179). Triple therapy consisted of PPI b.i.d., clarithromycin 500 mg b.i.d., and amoxicillin 1 g b.i.d. for 7 days. Yogurt group received triple therapy for 1 week and one bottle of Will yogurt per day for at 3 weeks, starting on the first day of triple therapy. Will yogurt (a Korean brand) contains Lactobacillus acidophilus HY2177, Lactobacillus casei HY2743, Bifidobacterium longum HY8001, and Streptococcus thermophilus B-1. C-13-urea breath test was performed at least 4 weeks after completion of triple therapy. Eradication rates, compliances, and adverse events were compared. Results: By intention-to treat analysis the H. pylori eradication rates in the yogurt group 79.2% (133 of 168) was similar to that in the control group 72.1% (129 of 179) (p = .124). However, by per-protocol (PP) analysis, the eradication rate in the yogurt group, 87.5% (133 of 152) was higher than that in the control group, 78.7% (129 of 164) (p = .037). Common adverse events were metallic taste (11.8%) and diarrhea (8.6%). The frequency of adverse effects in the yogurt group 41.1% (69/168) were higher than in the control group, 26.3% (47 of 179) (p = .003). However, most adverse events were mild to moderate in intensity, and the severities of adverse effects were similar in both groups (p = .401). Conclusions: The addition of Will yogurt to triple therapy did not reduce the side-effects of triple therapy. But it increased the H. pylori eradication rate by PP analysis, encouraging more research in this field.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 58 条
[1]  
Aiba Y, 1998, AM J GASTROENTEROL, V93, P2097, DOI 10.1111/j.1572-0241.1998.00600.x
[2]   The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy [J].
Armuzzi, A ;
Cremonini, F ;
Bartolozzi, F ;
Canducci, F ;
Candelli, M ;
Ojetti, V ;
Cammarota, G ;
Anti, M ;
De Lorenzo, A ;
Pola, P ;
Gasbarrini, G ;
Gasbarrini, A .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (02) :163-169
[3]   HELICOBACTER-PYLORI PHENOTYPES ASSOCIATED WITH PEPTIC-ULCERATION [J].
BLASER, MJ .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 :1-5
[4]   Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora [J].
Bühling, A ;
Radun, D ;
Müller, WA ;
Malfertheiner, P .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (09) :1445-1452
[5]   Inhibition of gastric mucin synthesis by Helicobacter pylori [J].
Byrd, JC ;
Yunker, CK ;
Xu, QS ;
Sternberg, LR ;
Bresalier, RS .
GASTROENTEROLOGY, 2000, 118 (06) :1072-+
[6]   A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates [J].
Canducci, F ;
Armuzzi, A ;
Cremonini, F ;
Cammarota, G ;
Bartolozzi, F ;
Pola, P ;
Gasbarrini, G ;
Gasbarrini, A .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (12) :1625-1629
[7]   Probiotics and Helicobacter pylori eradication [J].
Canducci, F ;
Cremonini, F ;
Armuzzi, A ;
Di Caro, S ;
Gabrielli, M ;
Santarelli, L ;
Nista, E ;
Lupascu, A ;
De Martini, D ;
Gasbarrini, A .
DIGESTIVE AND LIVER DISEASE, 2002, 34 :S81-S83
[8]   Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects [J].
Cats, A ;
Kuipers, EJ ;
Bosschaert, MAR ;
Pot, RGJ ;
Vandenbroucke-Grauls, CMJE ;
Kusters, JG .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (03) :429-435
[9]   Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection [J].
Cheon, JH ;
Kim, N ;
Lee, DH ;
Kim, JM ;
Kim, JS ;
Jung, HC ;
Song, IS .
HELICOBACTER, 2006, 11 (01) :46-51
[10]  
Chung SJ, 2007, HEPATO-GASTROENTEROL, V54, P1293